FDA Approves Orphan Drug Vandetanib For Advanced Medullary Thyroid Cancer
AstraZeneca (NYSE: AZN) has announced that the U.S. Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body. Vandetanib is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable ...

FDA Proposes Draft Menu And Vending Machine Labeling Requirements, Invites Public To Comment On Proposals
The U.S. Food and Drug Administration today issued two proposed regulations regarding calorie labeling on menus and menu boards in chain restaurants, retail food establishments, and vending machines. The FDA invites input on the proposed regulations by visiting here1. "These proposals will ensure that consumers have more information when they make their own food choices," said Department of ...